Abstract：
Despite the development and incorporation of new therapeutic strategies, such as biologic therapy and small molecules, corticosteroids still play an important role in inducting inflammatory bowel diseases (IBD) remission. Variables like indicating the right doses at the right time, in adequate intervals, the security of these drugs and the pharmacological alternatives available must be considered by the providers when they are indicated to patients with IBD. Although the use of corticosteroids is considered as a marker of quality of care in patients with IBD, the use of these drugs in the clinical practice of IBD is far from being the correct one. This review article is not intended to be just a classic review of the indications for corticosteroids. Here we explain the scenarios in which, in our opinion, steroids would not be an appropriate option for our patients, as well as the most frequent mistakes we make in our daily practice when using them.
摘要：
尽管开发和纳入了新的治疗策略，如生物治疗和小分子，糖皮质激素在诱导炎症性肠病(IBD)缓解中仍有重要作用。变量，如在正确的时间指示正确的剂量，在适当的时间间隔内，当向IBD患者提供药物时，提供者必须考虑这些药物的安全性和可用的药物替代品。尽管使用皮质类固醇被认为是IBD患者护理质量的标志，这些药物在IBD临床实践中的使用远不是正确的。这篇综述文章的目的不仅仅是对皮质类固醇适应症的经典综述。在这里我们解释的情况下，在我们看来,类固醇对我们的病人来说不是一个合适的选择，以及我们在日常练习中使用它们时最常犯的错误。
